Cargando…
Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury
BACKGROUND: The α(2)-adrenoreceptor agonist dexmedetomidine is known to provide neuroprotection under ischemic conditions. In this study we investigated whether dexmedetomidine has a protective effect in an in vitro model for traumatic brain injury. METHODS: Organotypic hippocampal slice cultures we...
Autores principales: | Schoeler, Marc, Loetscher, Philip D, Rossaint, Rolf, Fahlenkamp, Astrid V, Eberhardt, Georg, Rex, Steffen, Weis, Joachim, Coburn, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350422/ https://www.ncbi.nlm.nih.gov/pubmed/22494498 http://dx.doi.org/10.1186/1471-2377-12-20 |
Ejemplares similares
-
Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury
por: Loetscher, Philip D, et al.
Publicado: (2009) -
Propofol: neuroprotection in an in vitro model of traumatic brain injury
por: Rossaint, Jan, et al.
Publicado: (2009) -
Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury
por: Roehl, Anna B, et al.
Publicado: (2010) -
Early cognitive function, recovery and well-being after sevoflurane and xenon anaesthesia in the elderly: a double-blinded randomized controlled trial
por: Cremer, Jan, et al.
Publicado: (2011) -
Better haemodynamic stability under xenon anaesthesia than under isoflurane anaesthesia during partial nephrectomy – a secondary analysis of a randomised controlled trial
por: Schäfer, Patrick, et al.
Publicado: (2019)